TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 75 filers reported holding TRANSMEDICS GROUP INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $906,003 | -34.8% | 16,548 | 0.0% | 0.01% | -30.0% |
| Q2 2023 | $1,389,701 | +39.1% | 16,548 | +2.2% | 0.01% | +25.0% |
| Q4 2022 | $999,247 | +47.9% | 16,190 | 0.0% | 0.01% | +33.3% |
| Q3 2022 | $675,771 | +51.1% | 16,190 | +13.8% | 0.01% | +50.0% |
| Q2 2022 | $447,313 | +6.7% | 14,223 | -8.6% | 0.00% | +33.3% |
| Q1 2022 | $419,213 | +136.4% | 15,561 | +68.2% | 0.00% | +50.0% |
| Q4 2021 | $177,307 | -42.1% | 9,254 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $306,215 | -39.6% | 9,254 | -24.3% | 0.00% | -40.0% |
| Q1 2021 | $506,966 | +108.5% | 12,219 | 0.0% | 0.01% | +150.0% |
| Q4 2020 | $243,158 | +44.4% | 12,219 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $168,378 | -23.1% | 12,219 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $218,964 | +145.7% | 12,219 | +65.6% | 0.00% | +100.0% |
| Q1 2020 | $89,114 | -36.5% | 7,377 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $140,237 | – | 7,377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 923,221 | $30,632,000 | 5.64% |
| Sandhill Capital Partners LLC | 1,429,432 | $47,429,000 | 3.70% |
| Bullseye Asset Management LLC | 117,471 | $3,898,000 | 1.31% |
| Taylor Wealth Management Partners | 72,685 | $2,412,000 | 0.85% |
| Signature Wealth Management Partners, LLC | 14,000 | $465,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 369,259 | $12,252,000 | 0.40% |
| Triumph Capital Management | 20,051 | $622,000 | 0.36% |
| EMERALD ADVISERS, LLC | 300,464 | $9,969,000 | 0.36% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,347 | $2,533,000 | 0.30% |
| Bellevue Group AG | 729,989 | $24,221,000 | 0.24% |